Razpipadon (developmental codes CVL-871, PF-06669571, and PW-0464) is a dopamine receptor agonist which is under development for the treatment of dementia-related...
5 KB (365 words) - 09:45, 20 September 2024
A-86929, adrogolide, dihydrexidine, dinapsoline, doxanthrine, fenoldopam, razpipadon, SKF-81,297, SKF-82,958, SKF-89,145, tavapadon, and trepipam. They have...
28 KB (2,798 words) - 23:11, 22 October 2024
phase 3 clinical trials for Parkinson's disease. Mevidalen (LY-3154207) Razpipadon (CVL-871) Bezard E, Gray D, Kozak R, Leoni M, Combs C, Duvvuri S (2024)...
6 KB (410 words) - 02:00, 6 August 2024
Centrally acting dopamine D1-like receptor agonists like tavapadon and razpipadon and D1 receptor positive modulators like mevidalen and glovadalen are...
58 KB (6,079 words) - 06:16, 2 November 2024
attention deficit hyperactivity disorder (ADHD). Glovadalen (UCB-0022) Razpipadon (CVL-871) Tavapadon (CVL-751) "Mevidalen - Eli Lilly and Company". AdisInsight...
7 KB (544 words) - 01:37, 17 October 2024
like amphetamine and lisdexamfetamine Dopamine D1 receptor agonists like razpipadon Dopamine precursors like levodopa (L-DOPA) Catecholaminergic activity...
93 KB (10,159 words) - 11:41, 2 November 2024